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Nonribosomal peptide synthetases (NRPSs) are
modular proteins that produce peptide antibiotics
and siderophores. These enzymes act as catalytic
assembly lines where substrates, covalently bound
to integrated carrier domains, are delivered to adja-
cent catalytic domains. The carrier domains are
initially loaded by adenylation domains, which use
two distinct conformations to catalyze sequentially
the adenylation of the substrate and the thioesterifi-
cation of the pantetheine cofactor. We have used a
mechanism-based inhibitor to determine the crystal
structure of an engineered adenylation-carrier do-
main protein illustrating the intermolecular interac-
tion between the adenylation and carrier domains.
This structure enabled directedmutations to improve
the interaction between nonnative partner proteins.
Comparison with prior NRPS adenylation domain
structures provides insights into the assembly line
dynamics of these modular enzymes.
INTRODUCTION
Nonribosomal peptide synthetases (NRPSs) are modular
enzymes responsible for the production of peptide natural prod-
ucts (Fischbach and Walsh, 2006; Sieber and Marahiel, 2005).
Like the functionally similar polyketide synthases, NRPSs use
a modular architecture with multiple catalytic domains joined
as a single protein. Most commonly, each module adds one
amino acid to the nascent peptide. Within a module are peptidyl
carrier protein (PCP) domains that are posttranslationally
modified with the phosphopantetheine group of coenzyme A.
Bound to the pantetheine through a thioester linkage, amino
acid and peptide intermediates are delivered to adjacent cata-
lytic domains in an assembly line fashion. Upstream of the
PCP domains are adenylation domains that load the amino
acid onto the pantetheine cofactor (Gulick, 2009; Sieber and
Marahiel, 2005). The loaded amino acids serve as substrates
for condensation domains that catalyze peptide bond formation.
This process continues until the peptide is released by a thio-
esterase (TE) domain of the termination module. Although this188 Chemistry & Biology 19, 188–198, February 24, 2012 ª2012 Elselinear architecture is sometimes used for the complete peptide,
many NRPS clusters use several multidomain proteins, requiring
both intra- and intermolecular domain interactions for the
complete synthesis.
Escherichia coli contains a single NRPS that produces the
trilactone siderophore enterobactin from three copies of the
amide formed between 2,3-dihydroxybenzoic acid (DHB) and
serine (Raymond et al., 2003). The enzymes involved in entero-
bactin synthesis are encoded by six genes (Raymond et al.,
2003), although a proofreading thioesterase (Chen et al., 2009;
Leduc et al., 2007) and a small protein that enhances EntF ad-
enylation activity (Felnagle et al., 2010) also play a role in enter-
obactin synthesis. DHB is produced by the activities of EntA,
EntB, and EntC. EntC converts chorismic acid to isochorismate
(Liu et al., 1990). The isochorismatase domain of EntB catalyzes
the conversion of isochorismate to 2,3-dihydro-2,3-dihydroxy-
benzoic acid (Drake et al., 2006; Gehring et al., 1997), which is
then oxidized to DHB by EntA (Liu et al., 1989; Sundlov et al.,
2006). EntE, EntB, and EntF constitute the two-module NRPS
system (Rusnak et al., 1989; Sikora et al., 2010). EntE and the
EntB aryl carrier protein (ArCP) domain comprise the DHB-acti-
vation module, and EntF serves as the module for incorporation
of serine. EntE and EntF thus serve as examples of inter- and
intramolecular adenylation domains (Figures 1A and 1B).
Elegant biochemical and structural studies from the Walsh
laboratory have identified regions of the EntB PCP that interact
with neighboring domains. Alanine-scanning mutagenesis of
the surface of the PCP identified residues important for interac-
tions with the EntD pantethienyltransferase (Lai et al., 2006b) and
the EntF condensation domain (Lai et al., 2006a). The enrichment
approach using this library of mutants failed to identify a binding
surface for EntE, likely because the EntE interaction is not rate
limiting. In contrast, a positive selection strategy with the non-
cognate ArCP VibB identified residues that improved recognition
by EntE (Zhou et al., 2007). In this study, the most significant
enhancement resulted from a mutation of Asn38 to an aspartic
acid. Surprisingly, the homologous residue in EntB is also an
asparagine residue. Thus, the requirement that PCP domains
interact with multiple proteins means the wild-type carrier
domain may not be optimized for any one of its catalytic part-
ners. Additional efforts to probe the interaction of the EntE
adenylation and carrier protein surfaces before (Marshall et al.,
2002) or after (Drake et al., 2006) crystallization of EntB and the
EntE homolog DhbE (May et al., 2002) also provide only limited
insights into interacting residues for this functional interface.vier Ltd All rights reserved
Figure 1. Design of the EntE-B Chimeric Protein
(A and B) Inter- and intramolecular reactions catalyzed by EntE (A) and EntF (B). The two adenylation domains (blue) catalyze the initial adenylation of the
substrates DHB and serine, followed by the thioester-forming reactions with the pantetheine cofactor of the carrier domains (red) of EntB or EntF. Both reactions
result in the covalent loading of the pantetheine molecules. EntB also contains the isochorismatase domain (ICase) used in DHB synthesis.
(C) Amino acid alignment of two adenylation-carrier domain boundaries of multidomain NRPS enzymes EntF, DhbF, SrfAC, along with self-standing adenylation
domains DhbE and EntE, and the EntB ArCP domain. Highlighted are the A10 motif from the adenylation domains, PX4GK, and the site of phosphopantethei-
nylation, GXXS. The EntF linker (yellow) is used to model the linker of the EntE-B chimeric protein.
(D) Covalent loading of the EntE-B fusion protein. The holo-EntE-Bwas incubatedwith 14C-salicylic acid in the presence or absence of ATP, precipitated, washed,
and resuspended for scintillation counting. Error bars are standard deviations from triplicate experiments.
(E) Mechanism-based inhibitors 1 and 2 react with the pantetheine cofactor of the ArCP to form a dead-end trisubstrate analog. See also Figure S1 for sequence
information.
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Structure of an NRPS Adenylation-PCP InteractionStructures of representative members of NRPS core domains
have been determined, including the adenylation domains DhbE
(May et al., 2002), PheA (Conti et al., 1997), and BasE (Drake
et al., 2010); PCP domains of EntB (Drake et al., 2006) and
TycC3 (Koglin et al., 2006); and the condensation domain VibH
(Keating et al., 2000). The structure of a complete NRPS
module—the Bacillus subtilis surfactin synthetase SrfA-C—was
determined, providing valuable insights into the interdomain
architecture (Tanovic et al., 2008). This structure demonstrated
that the condensation domain and the N-terminal subdomain
of the adenylation domain interact to form a ‘‘platform’’ on which
the other domains and subdomains migrate to enable the
delivery of the substrate to alternate active sites. Modeling of
the pantetheine cofactor suggests that the carrier protein of
SrfA-Cwas properly positioned to interact with the condensation
domain. However, significant domain reorganizations are
necessary for the carrier protein domain to deliver the pante-
theine thiol to the other domains.Chemistry & Biology 19, 188NRPS adenylation domains are members of the ANL super-
family of adenylating enzymes that contains Acyl-CoA synthe-
tases, NRPS Adenylation domains, and beetle Luciferases. A
large conformational change has been observed for members
of this superfamily (Gulick, 2009). These adenylating enzymes
utilize a 140 rotation of the C-terminal domain to adopt two
distinct conformations that are used for the adenylation and
thiolation reactions (Gulick et al., 2003; Reger et al., 2008).
Importantly, these two conformations have been observed with
the self-standing NRPS adenylation domain, DltA (Du et al.,
2008; Yonus et al., 2008). Careful analysis of the interactions at
the active site suggests that subtle changes in the electrostatic
interactions between the mostly positively charged residues
of the enzyme and the negatively charged substrates, ATP and
the carboxylate of the amino acid, direct the course of the
catalytic reaction and allow the enzyme to adopt the multiple
conformations without a large energetic barrier between these
states (Kochan et al., 2009; Yonus et al., 2008).–198, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 189
Table 1. Ligand-Protein Dissociation Constants
Ligand EntE BasE VibE
1 63 ± 4.8 19 ± 2.2 5.3 ± 0.4
2 6.3 ± 0.4 12 ± 1.4 2.4 ± 0.3
S9 0.18 ± 0.00 0.18 ± 0.01 0.08 ± 0.00
See also Table S1 for loading efficiency. KD values (mM) were determined
by fluorescence polarization displacement assay.
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Structure of an NRPS Adenylation-PCP InteractionGiven the existence of these alternate catalytic states and the
need for large domain movements in multdomain NRPSs to
deliver the PCP to multiple active sites, it seems reasonable to
propose (Gulick, 2009; Tanovic et al., 2008) that the domain
alternation conformational change within the adenylation
domain in NRPSs may transport the PCP for distinct steps in
the NRPS catalytic cycle. To better understand NRPS interdo-
main interactions, we have produced a chimeric protein from
EntE and the ArCP domain of EntB. Linking the two domains
together, we hoped to stabilize an otherwise transient interaction
to promote crystallization. Potentially, this could also mimic the
intramolecular interaction seen in natural adenylation-PCP
proteins. Using a mechanism-based inhibitor, we determined
the structure of the trapped interaction between EntE and the
holo EntB carrier domain. The structure reveals a dimer of
intermolecular interactions with the adenylation domain in the
thioester-forming conformation. Finally, we used the interface
to guide mutational experiments that allowed us to improve the
interaction between heterologous NRPSs.
RESULTS
Strategy for Design and Analysis of the Interaction
between EntE and EntB
The catalytic and structural mechanism of the ANL adenylating
enzymes utilize, upon completion of the adenylation partial
reaction, a rotation of the C-terminal domain by 140 to adopt
a second conformation for the thioester-forming reaction
(Gulick, 2009). This large conformational change may also play
an integral role in the coordination of NRPS domain interactions.
A long-standing goal has therefore been the characterization of
multidomain adenylation-PCP NRPS proteins. The inherent
conformational flexibility of these enzymes presents significant
challenges to crystallization and structure determination.
To enable the structural investigation of a catalytically compe-
tent complex between the EntE adenylation domain and the
EntB carrier protein, we used two strategies to promote crystal-
lization. We used amechanism-based inhibitor (Qiao et al., 2007)
to form a covalent linkage between the pantetheine cofactor
of EntB and the tightly bound bisubstrate mimic within the
EntE active site. Also, because a stable interaction complex
of EntE and EntB could not be observed with analytical
techniques such as size-exclusion chromatography, we engi-
neered an adenylation-ArCP didomain construct through
genetic methods.
We aligned the sequences of self-standing adenylation do-
mains EntE and DhbE, the B. subtilis homolog, with natural
didomain adenylation-PCP constructs, including EntF, DhbF,
and SrfA-C (Figure 1C). Comparison of these sequences with190 Chemistry & Biology 19, 188–198, February 24, 2012 ª2012 Elsethe EntB aryl carrier protein domain suggested that as few as
four residues could serve to connect the two domains. We
designed a linker to incorporate a Gly-Arg-Ala-Ser, on the basis
of the residues present in EntF. We replaced the EntF proline
residue with a serine because of the nearby proline present at
EntB Pro213. This protein catalyzed the loading of 14C-salicylic
acid in an ATP-dependent manner (Figure 1D). To enable the
comparison with the structural coordinates, EntB residues are
described using their residue position in the fusion protein. For
example, Ser575 correlates to Ser245, the site of the pantetheine
cofactor (Figure S1 available online).
Ligands that mimic the adenylate or product have previously
been used to stabilize the two active conformations of ANL
enzymes (Gulick, 2009). We therefore used an inhibitor designed
to exploit the adenylation domain two-step reaction (Qiao et al.,
2007). Upon proper delivery of the pantetheine thiol of EntB
to the EntE active site, nucleophilic attack on the vinyl sulfon-
amide forms the stable mimic of the thioesterification step (Fig-
ure 1E). A similar strategy has recently been used for the study
of the E1 ubiquitin ligase (Olsen et al., 2010). An efficient and
versatile synthesis of the vinylsulfonamide inhibitors 1 and 2 is
described in the Supplemental Information.
As a first step to characterize ligands 1 and 2, we evaluated
their binding affinities using a fluorescence polarization displace-
ment assay with EntE employing the fluorescent probe S9
(Supplemental Information). The dissociation constant (KD) for
2$EntE was 6.3 mM. Ligand 1, which varies from 2 by removal
of the 3-hydroxy group, resulted in a ten-fold reduction in
potency, affording a KD of 63 mM (Table 1). To further confirm
the utility of these ligands, we evaluated their affinity to the
homologs BasE and VibE from Acinetobacter baumannii and
Vibrio cholerae, respectively, which also adenylate 2,3-dihydrox-
ybenzoic acid (Table 1). Overall, the relative affinities for 1 and 2
to EntE, BasE and VibE parallel the KM values found for the
substrates 2-hydroxybenzoic acid and 2,3-dihydroxybenzoic
acid (Drake et al., 2010; Keating et al., 2000; Rusnak et al., 1989).
The ability of 1 and 2 to be transferred by EntE onto the carrier
protein domain of EntB was next evaluated. Incubation of 1 mM
1 or 2 with 10 mM EntE and 10 mM EntB for 2 hr resulted in
complete labeling of EntB as measured by electrospray mass
spectrometry. The deconvoluted masses for labeled EntB
(35,480) precisely matched the expected mass (Table S1). In
the absence of EntE, only a negligible amount of labeling of
EntB by 1 or 2was observed under the same reaction conditions,
demonstrating the requirement for the adenylating enzyme. To
further assess the specificity of this process, the labeling of
EntB by 1 and 2 using the noncognate adenylating enzymes
BasE and VibE was tested under the same conditions. No
labeling of EntB was observed, possibly because of weaker
protein-protein interactions between the BasE/EntB and VibE/
EntB protein pairs.
Structure of the EntE-B Chimeric Protein
Both vinylsulfonamide inhibitors 1 and 2 enabled the crystalliza-
tion of EntE-B in a variety of morphologies and space groups.
The best diffraction was observed for a monoclinic crystal that
diffracted to 3.1 A˚ and included the salicylate-based ligand 1.
The initial model for molecular replacement was created using
the deposited structure of DhbE, a homolog of EntE (47%vier Ltd All rights reserved
Table 2. Crystallographic Data Collection and Refinement
Statistics
Data Collection EntE-B
Resolution 40–3.1 A˚
Space group P21
Unit cell a = 160.6 A˚
b = 101.8 A˚
c = 240.7 A˚
b = 107.1
Rmerge
a 6.8% (47.5%)
Completenessa 99.4% (100.0%)
I/sa 13.0 (1.8)
Redundancya 3.7 (3.7)
Refinement
Rcryst (Overall/Highest Resolution Shell)
a 21.8% (35.5%)
Rfree (Overall/Highest Resolution Shell)
a 26.4% (34.5%)
Wilson B-factor 90.4 A˚2
Average B-Factor, Protein 97.6 A˚2
Average B-Factor, Ligand 89.6 A˚2
Number of iodide ions 25
RMS Deviation bond lengths, angles 0.01 A˚, 1.36
aHighest resolution shell. Because of the high noncrystallographic
symmetry, Rfree reflections were generated in thin shells. The high resolu-
tion Rfree value is reported for data from 3.33–3.29 A˚.
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Structure of an NRPS Adenylation-PCP Interactionidentity) from B. subtilis (May et al., 2002), that had been crystal-
lized in the adenylate-forming conformation. Coordinates for the
C-terminal domain of DhbE were modeled into the thioester-
forming conformation using acetyl-CoA synthetase (Gulick
et al., 2003) as a template.
The structure determination required multiple iterations of
molecular replacement and manual model improvement with
noncrystallographic symmetry averaging, deleting loops that
differed between themultiple copies in the asymmetric unit. After
significantly improving the model for the EntE adenylation
domain, a two-model molecular replacement search using the
EntE model and the carrier domain from EntB was able to posi-
tion ten molecules of EntE and three molecules of EntB carrier
domain. Continued improvement of the EntE/EntB complex
allowed a final molecular replacement to identify the positions
of all 10 adenylation-ArCP domains. Statistics for data collection
and refinement are presented in Table 2.
The asymmetric unit of the EntE-B crystal structure contains
ten crystallographically independent EntE-B molecules (Fig-
ure 2A) arranged in five pairs of dimers. In each dimer, the
EntE adenylation domain interacts intermolecularly with the
EntB carrier domain from the other chain. Each of the ten protein
chains shows the full structure of the fusion protein, encompass-
ing Ser2 through Ala536 of EntE, the four residue linker, and the
ArCP domain from residues Ile541 to Arg612. The N-terminal
residues Met1, Ser2, and the C-terminal residues Ser611–
Lys615 are poorly ordered and are included in only some of
the chains. Additionally, chains B, F, and G are missing several
residues from the linker joining the EntE and EntB domains.
Each active site shows electron density (Figure 2B) for theChemistry & Biology 19, 188pantetheine covalently bound to the adenylate analog. At 3.1 A˚
resolution, no solvent molecules are included in the final model.
Multiple iodide ions from the crystallization cocktail were
included into spherical peaks of difference density greater than
5 s. The loop from residue 515 through 520, containing the cata-
lytic A10 lysine residue at position Lys520, is poorly ordered. A
lobe of unexplained density is positioned between the Pro514
residues from two adjacent molecules in the crystal lattice. The
electron density of the dimers formed from chains A and B, C
and H, and D and E are excellent given the resolution. The
electron density from the dimers composed of chains F and I,
as well as chains J and G, is worse; however, omit maps and
refinement statistics confirmed these chains are properly
positioned.
Structure of the EntE Adenylation Domain
EntE is composed of two subdomains (Figure 2C). Residues 1–
431 form the larger N-terminal domain, whereas residues 432–
536 make up the smaller C-terminal domain. Connecting the
N-terminal domain with the smaller C-terminal domain is a small
loop that includes a hinge residue, Lys432, about which the
C-terminal domain rotates (Gulick, 2009).
The EntE adenylation domain is in the conformation first
observed in the structure of bacterial acetyl-CoA synthetase
(Gulick et al., 2003) and subsequently confirmed biochemically
(Reger et al., 2008; Wu et al., 2008) as the conformation that
is competent for the thioester-forming partial reaction. The
C-terminal domain is formedby five b strands and three ahelices.
The substrate-binding pocket is located in a cleft between the
two subdomains of the adenylation domain. The adenine moiety
of the vinylsulfonamide inhibitor is bound on one side by the side
chain of Phe332 and the main chain atoms of Gly308-Gly309-
Ala310. The side chain of Asp415 binds the ribose hydroxyls.
The P-loop, a well-conserved motif containing multiple serine,
threonine, and glycine residues, is weakly ordered and adopts
different conformations in the ten chains.
The pantetheine approaches the EntE active site through
a tunnel that includes residues from two regions of EntE, which
also contribute to the EntB binding surface. Within the tunnel,
the pantetheine moiety is positioned similarly to the equivalent
atoms from the CoA molecule in related adenylating enzymes
(Gulick et al., 2003; Kochan et al., 2009; Reger et al., 2008).
Although the nucleotide portion of CoA in the CoA-ligases
adopts different conformations, the pantetheine moieties of all
enzymes, including EntE-B, adopt a similar conformation. As in
the prior structures, there are few binding interactions between
the pantetheine moiety and the encompassing protein tunnel.
Instead, only hydrogen bonds exist between pantetheine amide
nitrogens and the carboxyl oxygen atoms of Gly438 and Gly439.
Structure of EntB ArCP Domain
The ArCP domain of EntE-B is the typical four-helix bundle seen
in other PCP structures. The domain is similar to the full-length
EntB structure (rms distance of 0.8 A˚ over 65 residues) with the
most dissimilar region being a slight difference in the path of
Loop 1 between residues 557–561. This loop makes several
interactions with the EntE N-terminal domain, and these differ-
ences may reflect distinct conformational states of the com-
plexed and free EntB carrier domains. The solution structure of–198, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 191
Figure 2. Crystal Structure of the Fusion Protein EntE-B
(A) Ribbon representation of the ten protein chains present in the asymmetric unit. Each chain is shown in a different color with functionally interacting subunits
shown in similar colors.
(B) Electron density of the active site for Chain C EntE molecule. Unbiased electron density with coefficients of the form Fo-Fc calculated before the inclusion of
ligands is shown. The density is contoured at 3 s, centered on atom C5P of the pantetheine chain, and shown as a sphere with radius 12 A˚.
(C) Ribbon representation of the functional interaction between EntE and the EntB carrier protein domain. The N-terminal domain of EntE is shown with blue
helices and purple sheets, whereas the C-terminal domain is shown in green. The carrier domain is shown in red. The pantetheine cofactor and inhibitor are shown
in stick representation with yellow, red, blue, orange, and gold for carbon, oxygen, nitrogen, phosphorus, and sulfur, respectively.
(D) Two complete chains of the interacting dimer in green and blue. The EntE domain is shown in surface representation, and the PCP domain andC-terminal helix
of EntE are shown as ribbons.
(E) Stereorepresentation of the active site of EntE (in blue) with EntB shown in red. The cofactor and inhibitor are shown in ball-and-stick representation, colored
as in panel (A). Panels (B) and (E) are shown in the same orientation. See also Figure S2 for a comparison of the multiple copies in the asymmetric unit.
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Structure of an NRPS Adenylation-PCP Interactionthe TycC3 PCP domain adopts multiple conformational states
that are dependent on the pantetheinylation state (Koglin et al.,
2006). Two distinct states were identified for the apo and holo
forms (A and H state, respectively) and a third state (A/H state)
was shared by the two forms. The ArCP domain of the holo
EntB domain most closely represents the A/H state.
Interactions between EntB-ArCP and EntE
Rather than forming an intramolecular domain interaction, each
EntB ArCP domain interacts intermolecularly with the EntE
adenylation domain from a different protein chain (Figure 2D).
To facilitate the connectivity of the EntE and the PCP within the
chimeric molecule, the C-terminal helix of EntE is dissociated
from the rest of the C-terminal domain. In the stand-alone
adenylation domain DhbE (May et al., 2002), this helix makes
closer contacts to the C-terminal domain. This movement of
the helix is the largest change in the molecule that results from192 Chemistry & Biology 19, 188–198, February 24, 2012 ª2012 Elsethe chimeric construct. The EntE protein from chain A interacts
with the EntB ArCP domain from chain B; the chain B EntE
then interacts with the ArCP from chain A.
The asymmetric unit therefore contains five pairs of interacting
EntE-EntB fusion proteins. We compared the relative domain
orientation of each EntE and EntB pair within a single protein
chain (Figure S2), as well as the orientation between each EntE
molecule with the EntB domain that donates the pantetheine
cofactor to its active site (i.e., the intermolecular interaction
between EntE of chain A and the EntB of chain B). The orientation
between the two fused domains differed by as much as 10–15.
In contrast, the intermolecular interactions were nearly identical
in all ten EntE-EntB interfaces. Thus, the linker spanning the
EntE and EntB domains, and the C-terminal helix of EntE, adjust
the relative positions of the adenylation and ArCP domains
within one chain to enable constant interactions to exist in the
intermolecular EntE-EntB ArCP domain interactions.vier Ltd All rights reserved
Figure 3. Interactions between the EntE Adenylation and EntB Carrier Domains
(A) The interaction between EntE (gray surface) and EntB (ribbon) are shown; the EntE N-terminal domain is in darker gray. The two EntB regions of the interface
are helix 2 of the ArCP domain (purple) and the loop that precedes this helix (gold).
(B) Two views of the ArCP domain are shown, with residues that contribute to the interface shown as ball-and-stick models. The N and C termini of the carrier
domain are indicated with a blue and red sphere, respectively.
(C) The residues from EntE that contribute to the interface are shown in ball-and-stick representation. Arg494, Glu500, and Arg506 are highlighted, along with
Asp557 and Asp570, with which they interact. The homologous residues in BasE were targeted for improved recognition of EntB. See also Figure S3 for a stereo
representation.
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Structure of an NRPS Adenylation-PCP InteractionEntE EntB Interface as a Model for Adenylation-PCP
Interactions
Because each EntE molecule forms consistent interactions with
the ArCP that donates the pantetheine cofactor to its active site,
this interface likely represents the true intermolecular interface
between EntE and EntB. We first present the regions of the
two proteins that contribute to the interaction (Figure 3) and
then present our biochemical validation of the structural obser-
vations. We note that there are minor differences in the interact-
ing residues that result from changes in side chain positions that
are observed at 3.1 A˚ and focus on interactions that are present
in nearly all interfaces.
EntB interacts with EntE through two distinct surfaces, at loop
1 and helix 2. Loop 1, between the first two helices of the ArCP at
residues 556 through 574, interacts solely with the C-terminal
domain of EntE. The side chain of Asp557 forms salt bridges
with Arg490 and Arg506 of the C-terminal domain of EntE.
Additional ionic interactions occur between Asp566 of EntB
and Arg491 of EntE, as well as Asp570 of EntB through a sideChemistry & Biology 19, 188chain interaction with Arg494 and an interaction through its
main chain carbonyl with Arg490. Finally, Asp574, the residue
immediately preceding the cofactor binding site that was impli-
cated in the EntE-EntB interaction (Drake et al., 2006), creates
a salt bridge with Lys473 of the hairpin loop between the two
longest strands of the EntE C-terminal domain.
The ArCP domain helix 2, which starts at the pantetheinylation
site at Ser575, runs the length of the PCP domain on the opposite
side of Loop 1. Three residues from the EntE C-terminal domain
on the hairpin turn (Asp467-Gly471) between the two long
b strands interact with this helix. Asp467 interacts with Arg577,
whereas Leu469 and Met470, together with Leu285 from the
N-terminal domain, form a hydrophobic pocket for Val576 of
EntB. The remaining interactions of Helix 2 occur with the EntE
N-terminal domain. Helix 2 runs parallel to the helix of EntE
running from Pro280 to Glu292 forming both hydrophobic and
ionic interactions. Helix 2 additionally contacts Asp258-Thr262.
A specific hydrophobic interaction is seen between EntB
Met579 with EntE Leu285, whereas Arg584 and Lys587 interact–198, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 193
Table 3. Apparent Kinetic Constants for BasE Mutants with EntB
BasE EntE Mutant kcat (s
1) kcat/KM (s
1M1) KM (mM
1)
Wild-type BasE 0.44 ± 0.08 3.0 (±1.3) 3 104 14.7 ± 5.8
Met500 Arg494 M500R 1.38 ± 0.06 1.6 (±0.5) 3 106 0.84 ± 0.27
Gln506 Glu500 Q506E 0.05 ± 0.01 2.0 (±0.8) 3 103 27.6 ± 9.7
Gln512 Arg506 Q512R 1.67 ± 0.11 7.4 (±1.9) 3 105 2.26 ± 0.56
M500R/Q506E 3.00 ± 0.09 8.0 (±0.9) 3 105 3.76 ± 0.40
M500R/Q506E, Q512R 0.91 ± 0.07 1.5 (±0.3) 3 105 6.30 ± 1.30
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Structure of an NRPS Adenylation-PCP Interactionwith Glu292 through salt bridges. Interestingly, in the structure
of SrfA-C, the helix 2 of the PCP domain also stacks against
a helix from the condensation domain (Tanovic et al., 2008).
However, different residues from helix 2 in the two structures
form the interface with the neighboring condensation or adeny-
lation domains.
Ser575 is phosphopantetheinylated. The phosphate moiety
forms no ionic interactions with the EntE protein, although the
side chain of Arg437 of EntE is 4.5 A˚ from the phosphate
and may contribute a favorable electrostatic interaction; this
residue lies on the A8 loop five residues from the hinge between
the two subdomains. An arginine at this or the following position
on this loop is common, though not universal, in adenylation
domains.
We sought to validate biochemically the EntE-B structure.
Because prior attempts to disrupt the EntE-EntB interaction
have met with limited success, probably because of the require-
ment for multiple changes, we instead attempted to improve the
activity in a noncognate homolog. We compared the interacting
residues with those of homologous DHB-activating enzyme
pairs. In particular, we compared the EntE-EntB sequences to
the homologous proteins BasE and BasF from acinetobactin
biosynthesis in A. baumannii (Drake et al., 2010), DhbE and
DhbB from B. subtilis (May et al., 2002), and VibE and VibB
from V. cholerae (Keating et al., 2000). Certain interacting pairs
are conserved in all four pairs of proteins. For example Arg437
and Lys473 of EntE, which both interact with Asp574 of the
ArCP domain, are conserved in the enterobactin, acinetobactin,
bacillibactin, and vibriobactin systems. (VibE and DhbE have an
arginine in place of Lys473.) Similarly, the interaction between
Asp467 of EntE and Arg 577 of the ArCP is also maintained in
all four systems.
Other regions, which are not conserved in the sequence
alignments, stood out as maintaining realistic compensatory
substitutions in the alternate systems. Arg494 of EntE, which
interacts within EntE with Glu500, interacts across the interface
with Asp570 of EntB. Arg494 and Asp570 are conserved in
DhbE and DhbB and are replaced in the BasE/BasF system
with the hydrophobic residues methionine and leucine. In the
VibE/VibB system, the residues are replaced with aromatic
residues histidine and phenylalanine. Additionally, the EntE/
EntB interaction between Arg506 and Asp557 could be main-
tained by glutamine and glutamate in BasE/BasF, glutamine
and asparagine in VibE/VibB, and arginine and glutamine in
DhbE/DhbB.
We therefore mutated the BasE adenylation domain to
improve its ability to recognize EntB. BasE residues Met500,
Gln506, and Gln512 were mutated to mimic the equivalent194 Chemistry & Biology 19, 188–198, February 24, 2012 ª2012 ElseEntE residues Arg494, Glu500, and Arg506, respectively. We
also created the double mutant M500R/Q506E to recreate the
EntE Arg494-Glu500 interaction, and the triple mutant M500R/
Q506E/Q512R (Table 3).
We first assayed the ability of wild-type and mutant BasE
enzymes to load EntB with DHB using mass spectrometry.
Although BasE was able to load its natural partner BasF to
completion, BasE only loaded 25% of EntB under identical
conditions. The mutant BasE enzymes were then compared.
The Q506E mutant loaded only 15% of the EntB protein, but
the remaining mutants were able to load 40%–80% of the
EntB samples. Because the mass spectrometry results are
only semiquantitative, we next performed preliminary kinetic
experiments with the BasE enzymes and holo BasF and EntB
acceptors. The four mutant BasE enzymes showed 4–15 times
increase in initial velocity rates compared to wild-type BasE;
once again the Q506Ewas worse, showing a five times decrease
in the initial rate. The mutant enzymes had much smaller effect
on the initial rate with BasF, ranging from 0.7- to 3-fold changes
in the initial rate. In contrast to the results with the EntB acceptor,
the Q506E mutant showed elevated activity with BasF.
Encouraged by these results, we determined apparent kinetic
constants for the wild-type and mutant BasE enzymes recog-
nizing the EntB acceptor (Table 3). All mutations except the
Q506E singlemutant resulted in small increases in kcat and rather
dramatic increases in kcat/KM. The M500R and Q512R mutants
have 53- and 25-fold increases in kcat/KM relative to wild-type.
The combinations of mutations do not appear to be additive.
The kcat/KM value for the doublemutant Q506E/M500R is slightly
worse than that for the M500R mutation alone; however it is
27-fold higher than that of wild-type and 400-fold higher than
that of the Q506E mutation alone. The kcat/KM value for the triple
mutant is 5-fold higher than thewild-type enzyme. Thus, all of the
mutations improve the ability of BasE to recognize EntB, except
for the Q506E mutation. Gln506 was targeted in our study only
for its role in stabilizing the mutation of Met500 to arginine, on
the basis of the interaction between Glu500 and Arg494 of
EntE. It is therefore not surprising that the Q506E mutation did
not improve activity on its own. However, the Q506E mutant
did not further enhance the improvement seen in the M500R
mutant, suggesting that BasE may not adopt exactly the same
overall orientation as we observed in EntE.
DISCUSSION
We present here the structure of an engineered two-domain
NRPS composed of the adenylation domain of EntE joined
with a four-residue linker to the ArCP domain of EntB. The fusionvier Ltd All rights reserved
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a covalent adduct of the pantetheine cofactor that we observed
crystallographically. The protein crystallized as dimers of inter-
molecular interactions, where two adjacent EntE proteins
contributed their tethered PCP domains to the other chain. To
validate the interaction, we used this structure as a guide to
design mutations on the homologous BasE enzyme to improve
the ability of this enzyme to recognize the noncognate carrier
protein of EntB. This supports our contention that the intermo-
lecular interaction observed in our crystal structure accurately
reflects the natural interaction of EntE and EntB.
Analysis of additional NRPS adenylation-PCP sequences was
performed to probe whether the orientation of the EntE and EntB
proteins observed crystallographically could be used by alter-
nate systems. The conservation of residues across the interface
or the compensatory substitution of residues in a manner that
maintained a realistic interaction would both suggest that other
NRPS pairs utilize a similar interaction.
We identified 11 pairs of self-standing salicylate- or DHB-acti-
vating adenylating enzymes and their partner carrier domains
from different species. These EntE homologs range from 536 to
565 residues and share 42%–85% sequence identity. The
residue preceding the Ser site of cofactor addition is an aspartic
acid in all 11 carrier protein domains. This aspartic acid residue
interacts in EntE-B with the side chains of Lys473 and is posi-
tioned within 4 A˚ of Arg437. These two residues were mutated
previously in a biochemical analysis based on a model for the
potential interaction between EntE and EntB (Drake et al.,
2006). Mutation of Arg437 resulted in a ten fold decrease in
EntE activity, and the combined mutation of both residues re-
sulted in a 30-fold decrease. The Asp574 position also was
mutated and impacted activity, although the mutation also inter-
feredwith the pantetheinylation, preventing quantitative analysis.
All 11 EntE homologs maintain an arginine at position 437 and
a Lys or Arg at position 473. Although these ArCP domains
contain an aspartic acid that precedes the cofactor binding
site, resulting in a GxDS motif, examination of the sequences
of the natural multidomain sequences including EntF, DhbF,
and SrfA-C (Figure 1C), shows that the pantetheinylation serine
follows a histidine to produce a GGHS motif. The position occu-
pied by Arg437 in these multidomain NRPSs is replaced with an
Ile in EntF, both modules of DhbF, and SrfA-C. The sequences of
the adenylation domains include insertions around the Lys473
position, making a true alignment difficult. However, structurally
aligning the C-terminal domains of EntE or DhbE with the SrfA-C
adenylation C-terminal subdomains shows that Lys473 aligns
with SrfA-C Ser902. The best sequence alignment for the other
multidomain enzymes suggests that EntE Lys473 aligns with
Gln904 of EntF and Arg1970 of the second module of DhbF.
Thus, of the sequences queried, all (with DhbF being the sole
exception) provide positively charged residues to the carrier
proteins with a GxDS motif and neutral residues to the carrier
domains bearing a GGHS sequence.
The introduction of four residues from the EntF linker between
EntE and EntB was designed to allow the formation of an intra-
molecular interaction between the adenylation and carrier
domains within one protein chain. Unexpectedly, the protein
formed the intermolecular interaction between EntE and EntB
in a dimeric form where each chain donated the PCP domainChemistry & Biology 19, 188to the other EntE adenylation domain. On the basis of the BasE
results (Table 3), the conservation of the crystallographically
independent interactions (Figure S2), and the additional
sequence analysis discussed above, we believe that the inter-
molecular interface accurately reflects the interacting surfaces
of natural (i.e., nonfused) EntE and EntB. We do not, however,
believe that the dimeric structure (Figure 2D) is adopted by the
native EntE monomers (Gehring et al., 1998; Khalil and Pawelek,
2011) and EntB dimers (Drake et al., 2006) in their natural states.
Rather, once the pantetheine of one EntE-B protein molecule
chain reacts with the mechanism-based inhibitor of an alternate
EntE-B protein, locking two independent EntE-B molecules, the
proximity of the unreacted pantetheine and the second active
site facilitates formation of the dimeric complex.
The crystal structure of the SrfA-C termination module (Ta-
novic et al., 2008) demonstrated that large domain movements
must occur for the PCP domain to reach the other catalytic active
sites. Although the SrfA-C PCP domain was properly positioned
to interact with the condensation domain, the apo-carrier
domain was positioned too far to reach the alternate catalytic
domains, including the adjacent adenylation domains. There-
fore, the structure of the SrfA-C illustrates one functional confor-
mation of an NRPS module.
We superimposed the C-terminal subdomain from the SrfA-C
adenylation domain, as well as the adenylation-PCP linker onto
the thioester-forming conformation observed in the EntE-B
structure. In this model, the linker is indeed long enough to reach
from the A10 catalytic loop to the N terminus of the carrier
domain in the orientation observed in our intermolecular interac-
tion (Figure 4). The structure of EntE-B is therefore consistent
with the available linker structure provided by the SrfA-C struc-
ture (Tanovic et al., 2008). Additionally, we note that rotating
the adenylation C-terminal subdomain and PCP of SrfA-C into
a conformation similar to that observed in EntE-B does not
create any steric conflicts between domains. Thus, the intermo-
lecular interaction that we observed may be adopted by natural
two-domain adenylation-PCPs. The use of cognate mechanism-
based inhibitors to analyze additional proteins will demonstrate
conclusively whether a similar interaction is observed in both
intra- and intermolecular NRPS interactions.
In the thioester-forming conformation adopted by EntE-B, the
C-terminal domain creates a suitable interface for the binding of
the carrier protein. We propose that the domain alternation
(Gulick, 2009) strategy used by the NRPS adenylation domains
is one conformational rearrangement that enables the transport
of the carrier domain between different catalytic domains. In this
model, following amino acyl adenylation, the PCP domain is
delivered to the adenylation domain through a rotation of the
C-terminal subdomain of the adenylation domain. Completion
of thioesterification reaction and release of the loaded cofactor
would allow a return to an open state such as seen in SrfA-C
(Tanovic et al., 2008), enabling the delivery of the substrate to
the upstream condensation domain.
SIGNIFICANCE
We present here the structure of the interaction between an
NRPS adenylation domain and the holo carrier protein
domain. The structure of EntE-B builds on existing structural–198, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 195
Figure 4. Analysis of the C-Terminal Linker between Adenylation
and Carrier Domains
The C-terminal subdomain of the SrfA-C adenylation domain, shown in green,
was superimposed on the C-terminal subdomain of EntE (purple) within the
crystal structure of the chimeric protein.
(A) Alignment based on the full C-terminal domains results in the overlap of the
C terminus of the SrfA-C domain in the core of the ArCP domain of EntB (gold).
(B) Superposition of The C-terminal linker on the basis of the residues that form
the A10 loop (942–948 of SrfA-C and 514–520 of EntE) positions the C terminus
of SrfA-C (Pro969, green sphere) within 8 A˚ of the N-terminal residue of the
ArCP domain (Pro542, purple sphere).
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line strategy of these modular proteins. The structure
provides a view of the residues that form the interface and
allowed us to modify a homologous adenylating enzyme to
improve its recognition of the nonnative substrate. The use
of mechanism-based inhibitors is a powerful tool that
not only reduces the dynamics and fosters crystallization
of these large, multidomain enzymes, but also provides
unprecedented insights into the active sites of these fasci-
nating molecular machines.
EXPERIMENTAL PROCEDURES
Determination of Binding Affinity of 1 and 2 to Adenylating Enzymes
The dissociation constants of 1 and 2 with EntE, BasE, and VibE were evalu-
ated using a fluorescence polarization displacement assay employing ligand196 Chemistry & Biology 19, 188–198, February 24, 2012 ª2012 ElseS9 (Neres et al., 2008). A three fold serial dilution of inhibitor (228–1500 nM
and 76–500 nM for 1 and 2, respectively) was added to 20 nM S9 and
200 nM adenylating enzyme in reaction buffer (30 mM Tris [pH 7.5], 1 mM
MgCl2, and 0.0025% Igepal CA-630) in a total of 50 ml in 364-well black plates
(Corning 3575) and was read in duplicate on an Analyst AD (LJL) using an
excitation of 485 nm and an emission of 530 nm. Fluorescence anisotropy
was measured after a 30 min incubation at 25C. Following the determination
of the dissociation constant of the fluorescent probe S9 for each adenylating
enzyme, the KD values of 1 and 2 were determined by fitting the displacement
curves (AOBS versus LT) to Equations S1 and S3 (see Supplemental Experi-
mental Procedures) using Mathematica 7 (Wolfram Research Inc.), where
AOBS is the observed anisotropy and LT is the respective ligand concentration.
EntB-Labeling Assay
Reaction mixtures (100 ml final volume) containing 10 mM adenylating enzyme,
10 mM EntB, 1.0 mM inhibitor 1 or 2, 1.0 mM TCEP, and 1 mM MgCl2 in 5 mM
NH4HCO3 [pH 8.0] were incubated for 2 hr at 37
C. Solutions were diluted
20 times in ESI running buffer (70:30 water:acetonitrile, 0.1% formic acid)
and were directly injected into a Perkin Elmer Qstar XL using a 10 ml loop with a
flow rate of 10 ml/min.
Cloning, Linker Design, Expression, and Purification of EntE-B
The entE and entB genes were cloned from E. coli JM109 (Drake et al., 2006).
The ArCP region of entB was inserted downstream of entE following a 12 bp
linker encoding Gly-Arg-Ala-Ser. The engineered gene was cloned into a
pET15b vector encoding an N-terminal 5x His-tag sequence and TEV protease
recognition site (Kapust et al., 2001). Holo-EntE-B was produced in BL21-DE3
cells grown at 37C in minimal media (Drake et al., 2006), which induces
EntD to phosphopantetheinylate the ArCP. After the addition of 1 mM IPTG,
the cells were incubated for 3 hr. Purified EntE-B was obtained using two
nickel-affinity chromatographic steps. Cells were lysed by sonication in
25 mM HEPES [pH 7.5], 250 mM NaCl, 10% glycerol, 0.2 mM TCEP, and
10 mM imidazole. The lysate was passed over a 5-mL Ni2+,HiTrap Chelating
HP column (GE Healthcare); bound proteins were eluted with 300 mM
imidazole. Fractions showing EntE-B by SDS-PAGE analysis were dialyzed
over night with TEV protease in cleavage buffer (25 mM HEPPS [pH 8.0],
150 mM NaCl, 10% glycerol, 0.2 mM TCEP, and 0.5 mM EDTA). Imidazole
was added to 10mM, and the dialyzed protein was passed over a nickel affinity
column a second time. Flow-through fractions were collected for dialysis into
10 mM HEPES (pH 7.5), 20 mM NaCl, and 0.2 mM TCEP. The protein was
concentrated to 30 mg/ml.
Crystallization of EntE-B and Structure Determination
Crystallization conditions were identified from sparse matrix screening (Luft
et al., 2003). Crystals were grown at 20C by the microbatch under oil crystal-
lization method with a precipitant containing 20%–30% PEG 3350, 100 mM
ammonium iodide, and 50 mM MES (pH 6.0). Crystals were cryoprotected in
10%–20% PEG 3350, 75 mM ammonium iodide, 25 mM MES (pH 6.0), and
8%–24% MPD. Diffraction data were collected remotely (Soltis et al., 2008)
at SSRL beamline 11-1. Careful analysis for twinning or alternate spacegroups
with phenix.xtriage (Adams et al., 2010) confirmed the space group determina-
tion. Matthews coefficient analysis suggested that the monoclinic unit cell
could contain between six and 12 independent copies of EntE-B in the
asymmetric unit, yielding between 45% and 75% solvent content. Determina-
tion of the EntE-B structure required iterative molecular replacement and
model building to find the multiple copies. The initial model was derived
from the homolog DhbE (May et al., 2002), modeled to the thioester-forming
conformation and with side chains mutated to the EntE sequence. Molecular
replacement with PHASER (McCoy et al., 2007) identified a solution with six
chains. The initial electron density maps demonstrated an AMP moiety in the
active site, lending confidence to the accuracy of the solution. Molecular
averaging using CCP4 (CCP4, 1994) and manual refinement with COOT
(Emsley and Cowtan, 2004) resulted in an improved EntE model. This model
was used as an input to BALBES (Long et al., 2008), which located another
four EntE chains in the asymmetric unit. The ten chains were improved through
a second round of averaging and model-building. A two-model molecular
replacement search with the improved EntE and the EntB ArCP models with
PHASER identified ten chains of EntE and three of EntB. Each ArCP domainvier Ltd All rights reserved
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tunnel. Thus, the EntE-ArCP complex was used in a final molecular replace-
ment search to find ten functional complexes. Continued iterative refinements
and manual model building with COOT, REFMAC (Murshudov et al., 1997),
and PHENIX (Adams et al., 2010) allowed placement of ligands and of the
loops joining the EntE and EntB ArCP domains. Refinement methods
included TLS parameterization and NCS restraints, both at the level of protein
domains (the two subdomains of EntE and the EntB ArCP), and the use of
thin R-free shells to reduce bias from the NCS. The model was analyzed
with MOLPROBITY (Chen et al., 2010) and resided in the 93rd percentile for
clash score and 99th percentile for final MOLPROBITY score, relative to
structures of comparable resolution (Table 2).
Radioassay for Adenylate- and Thioester-Forming Activity of EntE-B
Activity of the EntE-B enzyme was determined with 14C-salicylic acid (Perkin
Elmer) as an alternate substrate (Gehring et al., 1998; Rusnak et al., 1989).
Assays included 50 mM HEPES buffer (pH 7.5), 5 mM MgCl2, 1 mM TCEP,
and 2 mM 14C-salicylic acid. A 1 hr reaction containing 20 mM EntE-B with
and without 1 mM ATP at 37C was quenched and protein precipitated
with 20% trichloroacetic acid. The protein pellet was washed three times
with acetone, dried, and resuspended in 8 M urea. The incorporated label
was quantified through liquid scintillation counting.
Determination of Apparent Kinetic Constants for BasE Mutants
with EntB
Initial velocity studies of the BasE reactionwith EntBwere assayed spectopho-
tometrically by coupling the formation of pyrophosphate to the reactions of
inorganic pyrophosphatase and purine nucleoside phosphorylase employing
the chromogenic substrate 2-amino-6-mercapto-7-methylpurine ribonucleo-
side (MesG, Berry & Associates, Dexter, MI), which is converted to 2-amino-
6-mercapto-7-methylpurine as described elsewhere (Webb, 1992). The
increase in absorbance of 2-amino-6-mercapto-7-methylpurine at 360 nM
(ε360 = 11,000 M
1 cm1) was measured at 25C using a Molecular Devices
M5e multimode plate reader. The standard reaction mixture contained
50 mM Tris (pH 8.0), 5 mM MgCl2, 2.5 mM ATP, 1 mM TCEP, 5 nM BasE
(wt or mutant), 0.25 mM 2,3-dihydroxybenzoic acid (DHB), 0.4 U/ml inorganic
pyrophosphatase (Sigma-Aldrich), 1 U/ml purine nucleoside phosphorylase
(Sigma-Aldrich), and 0.2 mM MesG in a final volume of 100 ml in 96 well UV
transparent microplates (Corning 3679). After incubation for 1 min at 25C,
reactions were initiated by the addition of 10 ml EntB (0.94–30 mM in 20 mM
Tris [pH 8.0], 1 mM TCEP, and 5% glycerol), and were followed for 20 min.
Enzymatic reactions were corrected for background activity (i.e., the increase
in absorbance caused by hydrolysis of ATP and/or MesG). Kinetic constants
for EntB were determined at fixed saturating concentrations of both
ATP and DHB. Initial velocities were determined with at least six different
concentrations of EntB. Initial substrate saturation kinetic data were fitted
using the Michaelis-Menten equation to determine the kinetic parameters
using Prism (version 4.0c). EntB was purified as described elsewhere (Sikora
et al., 2010).
ACCESSION NUMBER
The coordinates and structure factors of the EntE-B protein have been depos-
ited with the Protein Data Bank (3RG2).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.chembiol.2011.11.013.
ACKNOWLEDGMENTS
This work is supported in part by the National Institutes of Health (grant
GM-068440 to A.M.G.). Diffraction data were collected at the Stanford
Synchrotron Radiation Lightsource, a Directorate of SLAC National Acceler-
ator Laboratory and an Office of Science User Facility operated for the U.S.Chemistry & Biology 19, 188Department of Energy Office of Science by Stanford University. The SSRL
Structural Molecular Biology Program is supported by the DOE Office of
Biological and Environmental Research, and by the National Institutes of
Health, National Center for Research Resources, Biomedical Technology
Program (grant P41RR001209), and the National Institute of General Medical
Sciences.
Received: October 6, 2011
Revised: November 17, 2011
Accepted: November 22, 2011
Published: February 23, 2012
REFERENCES
Adams, P.D., Afonine, P.V., Bunko´czi, G., Chen, V.B., Davis, I.W., Echols, N.,
Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010).
PHENIX: a comprehensive Python-based system for macromolecular struc-
ture solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221.
Chen, D., Wu, R., Bryan, T.L., and Dunaway-Mariano, D. (2009). In vitro kinetic
analysis of substrate specificity in enterobactin biosynthetic lower pathway
enzymes provides insight into the biochemical function of the hot dog-fold
thioesterase EntH. Biochemistry 48, 511–513.
Chen, V.B., Arendall, W.B., 3rd, Headd, J.J., Keedy, D.A., Immormino, R.M.,
Kapral, G.J., Murray, L.W., Richardson, J.S., and Richardson, D.C. (2010).
MolProbity: all-atom structure validation for macromolecular crystallography.
Acta Crystallogr. D Biol. Crystallogr. 66, 12–21.
Collaborative Computational Project, Number 4. (1994). The CCP4 suite:
programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr.
50, 760–763.
Conti, E., Stachelhaus, T., Marahiel, M.A., and Brick, P. (1997). Structural basis
for the activation of phenylalanine in the non-ribosomal biosynthesis of gram-
icidin S. EMBO J. 16, 4174–4183.
Drake, E.J., Nicolai, D.A., and Gulick, A.M. (2006). Structure of the EntB
multidomain nonribosomal peptide synthetase and functional analysis of its
interaction with the EntE adenylation domain. Chem. Biol. 13, 409–419.
Drake, E.J., Duckworth, B.P., Neres, J., Aldrich, C.C., and Gulick, A.M. (2010).
Biochemical and structural characterization of bisubstrate inhibitors of BasE,
the self-standing nonribosomal peptide synthetase adenylate-forming enzyme
of acinetobactin synthesis. Biochemistry 49, 9292–9305.
Du, L., He, Y., and Luo, Y. (2008). Crystal structure and enantiomer selection
by D-alanyl carrier protein ligase DltA from Bacillus cereus. Biochemistry 47,
11473–11480.
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular
graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132.
Felnagle, E.A., Barkei, J.J., Park, H., Podevels, A.M., McMahon, M.D., Drott,
D.W., and Thomas, M.G. (2010). MbtH-like proteins as integral components
of bacterial nonribosomal peptide synthetases. Biochemistry 49, 8815–8817.
Fischbach, M.A., and Walsh, C.T. (2006). Assembly-line enzymology for poly-
ketide and nonribosomal peptide antibiotics: logic, machinery, and mecha-
nisms. Chem. Rev. 106, 3468–3496.
Gehring, A.M., Bradley, K.A., and Walsh, C.T. (1997). Enterobactin biosyn-
thesis in Escherichia coli: isochorismate lyase (EntB) is a bifunctional enzyme
that is phosphopantetheinylated by EntD and then acylated by EntE using ATP
and 2,3-dihydroxybenzoate. Biochemistry 36, 8495–8503.
Gehring, A.M., Mori, I., and Walsh, C.T. (1998). Reconstitution and character-
ization of the Escherichia coli enterobactin synthetase from EntB, EntE, and
EntF. Biochemistry 37, 2648–2659.
Gulick, A.M. (2009). Conformational dynamics in the Acyl-CoA synthetases,
adenylation domains of non-ribosomal peptide synthetases, and firefly lucif-
erase. ACS Chem. Biol. 4, 811–827.
Gulick, A.M., Starai, V.J., Horswill, A.R., Homick, K.M., and Escalante-
Semerena, J.C. (2003). The 1.75 A crystal structure of acetyl-CoA synthetase
bound to adenosine-50-propylphosphate and coenzyme A. Biochemistry 42,
2866–2873.–198, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 197
Chemistry & Biology
Structure of an NRPS Adenylation-PCP InteractionKapust, R.B., To¨zse´r, J., Fox, J.D., Anderson, D.E., Cherry, S., Copeland, T.D.,
andWaugh, D.S. (2001). Tobacco etch virus protease: mechanism of autolysis
and rational design of stable mutants with wild-type catalytic proficiency.
Protein Eng. 14, 993–1000.
Keating, T.A., Marshall, C.G., andWalsh, C.T. (2000). Vibriobactin biosynthesis
in Vibrio cholerae: VibH is an amide synthase homologous to nonribosomal
peptide synthetase condensation domains. Biochemistry 39, 15513–15521.
Khalil, S., and Pawelek, P.D. (2011). Enzymatic adenylation of 2,3-dihydroxy-
benzoate is enhanced by a protein-protein interaction between Escherichia
coli 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (EntA) and 2,3-dihy-
droxybenzoate-AMP ligase (EntE). Biochemistry 50, 533–545.
Kochan, G., Pilka, E.S., von Delft, F., Oppermann, U., and Yue, W.W. (2009).
Structural snapshots for the conformation-dependent catalysis by human
medium-chain acyl-coenzyme A synthetase ACSM2A. J. Mol. Biol. 388,
997–1008.
Koglin, A., Mofid, M.R., Lo¨hr, F., Scha¨fer, B., Rogov, V.V., Blum, M.M., Mittag,
T., Marahiel, M.A., Bernhard, F., and Do¨tsch, V. (2006). Conformational
switches modulate protein interactions in peptide antibiotic synthetases.
Science 312, 273–276.
Lai, J.R., Fischbach, M.A., Liu, D.R., and Walsh, C.T. (2006a). A protein inter-
action surface in nonribosomal peptide synthesis mapped by combinatorial
mutagenesis and selection. Proc. Natl. Acad. Sci. USA 103, 5314–5319.
Lai, J.R., Fischbach, M.A., Liu, D.R., and Walsh, C.T. (2006b). Localized
protein interaction surfaces on the EntB carrier protein revealed by combina-
torial mutagenesis and selection. J. Am. Chem. Soc. 128, 11002–11003.
Leduc, D., Battesti, A., and Bouveret, E. (2007). The hotdog thioesterase EntH
(YbdB) plays a role in vivo in optimal enterobactin biosynthesis by interacting
with the ArCP domain of EntB. J. Bacteriol. 189, 7112–7126.
Liu, J., Duncan, K., andWalsh, C.T. (1989). Nucleotide sequence of a cluster of
Escherichia coli enterobactin biosynthesis genes: identification of entA and
purification of its product 2,3-dihydro-2,3-dihydroxybenzoate dehydroge-
nase. J. Bacteriol. 171, 791–798.
Liu, J., Quinn, N., Berchtold, G.A., and Walsh, C.T. (1990). Overexpression,
purification, and characterization of isochorismate synthase (EntC), the first
enzyme involved in the biosynthesis of enterobactin from chorismate.
Biochemistry 29, 1417–1425.
Long, F., Vagin, A.A., Young, P., and Murshudov, G.N. (2008). BALBES:
a molecular-replacement pipeline. Acta Crystallogr. D Biol. Crystallogr. 64,
125–132.
Luft, J.R., Collins, R.J., Fehrman, N.A., Lauricella, A.M., Veatch, C.K., and
DeTitta, G.T. (2003). A deliberate approach to screening for initial crystalliza-
tion conditions of biological macromolecules. J. Struct. Biol. 142, 170–179.
Marshall, C.G., Burkart, M.D., Meray, R.K., and Walsh, C.T. (2002). Carrier
protein recognition in siderophore-producing nonribosomal peptide synthe-
tases. Biochemistry 41, 8429–8437.
May, J.J., Kessler, N., Marahiel, M.A., and Stubbs, M.T. (2002). Crystal struc-
ture of DhbE, an archetype for aryl acid activating domains of modular nonri-
bosomal peptide synthetases. Proc. Natl. Acad. Sci. USA 99, 12120–12125.
McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C.,
and Read, R.J. (2007). Phaser crystallographic software. J. Appl. Cryst. 40,
658–674.198 Chemistry & Biology 19, 188–198, February 24, 2012 ª2012 ElseMurshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997). Refinement of macro-
molecular structures by the maximum-likelihood method. Acta Crystallogr. D
Biol. Crystallogr. 53, 240–255.
Neres, J., Wilson, D.J., Celia, L., Beck, B.J., and Aldrich, C.C. (2008). Aryl acid
adenylating enzymes involved in siderophore biosynthesis: fluorescence
polarization assay, ligand specificity, and discovery of non-nucleoside inhibi-
tors via high-throughput screening. Biochemistry 47, 11735–11749.
Olsen, S.K., Capili, A.D., Lu, X., Tan, D.S., and Lima, C.D. (2010). Active site
remodelling accompanies thioester bond formation in the SUMO E1. Nature
463, 906–912.
Qiao, C., Wilson, D.J., Bennett, E.M., and Aldrich, C.C. (2007). A mechanism-
based aryl carrier protein/thiolation domain affinity probe. J. Am. Chem. Soc.
129, 6350–6351.
Raymond, K.N., Dertz, E.A., and Kim, S.S. (2003). Enterobactin: an archetype
for microbial iron transport. Proc. Natl. Acad. Sci. USA 100, 3584–3588.
Reger, A.S., Wu, R., Dunaway-Mariano, D., and Gulick, A.M. (2008). Structural
characterization of a 140 degrees domain movement in the two-step reaction
catalyzed by 4-chlorobenzoate:CoA ligase. Biochemistry 47, 8016–8025.
Rusnak, F., Faraci, W.S., and Walsh, C.T. (1989). Subcloning, expression, and
purification of the enterobactin biosynthetic enzyme 2,3-dihydroxybenzoate-
AMP ligase: demonstration of enzyme-bound (2,3-dihydroxybenzoyl)adeny-
late product. Biochemistry 28, 6827–6835.
Sieber, S.A., and Marahiel, M.A. (2005). Molecular mechanisms underlying
nonribosomal peptide synthesis: approaches to new antibiotics. Chem. Rev.
105, 715–738.
Sikora, A.L.,Wilson, D.J., Aldrich, C.C., and Blanchard, J.S. (2010). Kinetic and
inhibition studies of dihydroxybenzoate-AMP ligase from Escherichia coli.
Biochemistry 49, 3648–3657.
Soltis, S.M., Cohen, A.E., Deacon, A., Eriksson, T., Gonza´lez, A., McPhillips,
S., Chui, H., Dunten, P., Hollenbeck, M., Mathews, I., et al. (2008). New para-
digm for macromolecular crystallography experiments at SSRL: automated
crystal screening and remote data collection. Acta Crystallogr. D Biol.
Crystallogr. 64, 1210–1221.
Sundlov, J.A., Garringer, J.A., Carney, J.M., Reger, A.S., Drake, E.J., Duax,
W.L., and Gulick, A.M. (2006). Determination of the crystal structure of EntA,
a 2,3-dihydro-2,3-dihydroxybenzoic acid dehydrogenase from Escherichia
coli. Acta Crystallogr. D Biol. Crystallogr. 62, 734–740.
Tanovic, A., Samel, S.A., Essen, L.O., andMarahiel, M.A. (2008). Crystal struc-
ture of the termination module of a nonribosomal peptide synthetase. Science
321, 659–663.
Webb, M.R. (1992). A continuous spectrophotometric assay for inorganic
phosphate and for measuring phosphate release kinetics in biological
systems. Proc. Natl. Acad. Sci. USA 89, 4884–4887.
Wu, R., Cao, J., Lu, X., Reger, A.S., Gulick, A.M., and Dunaway-Mariano, D.
(2008). Mechanism of 4-chlorobenzoate:coenzyme a ligase catalysis.
Biochemistry 47, 8026–8039.
Yonus, H., Neumann, P., Zimmermann, S., May, J.J., Marahiel, M.A., and
Stubbs, M.T. (2008). Crystal structure of DltA: implications for the reaction
mechanism of non-ribosomal peptide synthetase adenylation domains.
J. Biol. Chem. 283, 32484–32491.
Zhou, Z., Lai, J.R., and Walsh, C.T. (2007). Directed evolution of aryl carrier
proteins in the enterobactin synthetase. Proc. Natl. Acad. Sci. USA 104,
11621–11626.vier Ltd All rights reserved
